T0	Participants 177 338	patients with periarthritis pain of the shoulder previously unsuccessfully treated with nonsteroidal anti-inflammatory drugs other than diclofenac and oxaprozin.
T1	Participants 404 456	eligible patients with periarthritis of the shoulder
T2	Participants 772 802	patient-assessed shoulder pain
T3	Participants 889 970	patient-assessed quality of life on the Short-Form-36 (SF-36) Acute Health Survey
T4	Participants 1968 2058	Patients also assessed the overall efficacy of oxaprozin as superior to that of diclofenac
T5	Participants 2469 2523	patients with periarthritis of the shoulder refractory